Krystal Biotech EBIT 2017-2024 | KRYS

Krystal Biotech EBIT for the quarter ending September 30, 2024 was $0.022B, a 186.3% decline year-over-year.

  • Krystal Biotech 2023 EBIT was -0.11B, a 24.43% decline from 2022.
  • Krystal Biotech 2022 EBIT was -0.145B, a 112.66% increase from 2021.
  • Krystal Biotech 2021 EBIT was -0.068B, a 106.9% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Krystal Biotech EBIT 2017-2024 | KRYS

  • Krystal Biotech 2023 EBIT was -0.11B, a 24.43% decline from 2022.
  • Krystal Biotech 2022 EBIT was -0.145B, a 112.66% increase from 2021.
  • Krystal Biotech 2021 EBIT was -0.068B, a 106.9% increase from 2020.

EBIT can be defined as earnings before interest and taxes.